Improving Maternal and Neonatal Care-seeking Through a Video-informed Training Session During the Third Trimester of Pregnancy (Taabo T3)

Improving Maternal and Neonatal Care-Seeking Through a Video-Informed Training Session During the Third Trimester of Pregnancy

This study is a randomized controlled trial evaluating the impact of a video-informed training session on maternal and newborn health care seeking in rural Côte d'Ivoire.

Study Overview

• Status: Not yet recruiting
• Conditions: Pregnancy; Maternal Health; Postpartum Care; Neonatal Health
• Intervention / Treatment: Other: Information video and planning session

Detailed Description

In Taabo, Côte d'Ivoire, many women do not receive recommended care during the third trimester of pregnancy or the early postpartum period, contributing to adverse maternal and neonatal health outcomes. In this individual-level open-label randomized controlled trial, we will evaluate the impact of an information and planning intervention on timely care-seeking during the third trimester of pregnancy and the early postpartum period. The study will enroll 800 women who are currently in the third trimester of pregnancy and randomize them to one of two groups: (1) control, or (2) information video and planning session for the pregnant women and her partner. A baseline survey will be performed at the time of enrollment, and outcomes will be evaluated using an endline survey 6-8 weeks after the end of pregnancy. The main outcome of the study is the number of health care contacts that women have between enrollment in the study and 6 weeks postpartum.

• Study Type: Interventional
• Enrollment (Estimated): 800
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Côte d’Ivoire
  • Taabo, Côte d’Ivoire
    • Centre Suisse de Recherches Scientifiques en Cote d'Ivoire
    • Contact: Siaka Koné, PhD; Phone Number: +2250749069627; Email: Siaka.kone@csrs.ci

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria for Pregnant Women:

• Currently pregnant
• Aged 15 years or older
• Live in the area served by the Taabo Health & Demographic Surveillance System
• Estimated gestational age between 6 completed months of pregnancy and 8 completed months of pregnancy

Inclusion Criteria for Male Partners:

• Aged 15 or older
• Married to or currently the main romantic partner of a woman who is enrolled in the study

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Control group; This group will not receive any intervention.
Experimental: Information Video and Planning Session group; This group will receive the study intervention, including an information video and planning session for the pregnant woman and her partner.	Other: Information video and planning session; The study intervention is a video-informed information and planning session for health care during the third trimester, childbirth, and the first six weeks postpartum. In this intervention, a member of the study team will show information videos to pregnant women and her partner, summarizing key recommendations for health and health care seeking during the third trimester of pregnancy and the first six weeks following childbirth. After showing the videos, the study team member will guide the pregnant woman and her partner in a short discussion about planning for care-seeking during the third trimester and early postpartum period. This discussion will include quizzing on the content of the information videos and discussions of care-seeking plans together with the couple.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of health care contacts as reported by women during endline survey	Number of health care contacts that women have between enrollment in the study and 6 weeks postpartum, including antenatal care visits, childbirth, and postpartum care visits	From enrollment to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of antenatal care visits as reported by women during endline survey	Number of antenatal care visits	Between enrollment and the end of pregnancy (measured 6-8 weeks after the end of pregnancy)
Facility-based childbirth as reported by women during endline survey	Proportion of women who gave birth in a health facility	Measured 6-8 weeks after the end of pregnancy
Number of postpartum visits as reported by women during endline survey	Number of postpartum care visits between the end of pregnancy and 6 weeks postpartum	From the end of pregnancy to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
Fetal movement counting as reported by women during endline surveys	The proportion of pregnant women who report counting fetal movements at least once during the final month of their pregnancy	Measured 6-8 weeks after the end of pregnancy
Perinatal mortality as reported by women during endline surveys	The proportion of women who experience a stillbirth or neonatal death in the first seven days of life (perinatal mortality)	Measured 6-8 weeks after end of pregnancy
Neonatal mortality as reported by women during endline surveys	The proportion of women whose child dies in the first 28 days of life	Measured 6-8 weeks after end of pregnancy
Average care-seeking knowledge scores among pregnant women and their partners	Average scores (among pregnant women and their partners) on assessments of knowledge of care-seeking recommendations during the third trimester and the early postpartum period, as measured using five questions during endline surveys with pregnant women and their partners. We create a Care-Seeking Knowledge Scale as follows: Participants receive 1 point if they respond with 3 or more when asked how many postpartum visits women should have during the first 6 weeks after childbirth; 1 point if they correctly name at least 3 danger signs for women during pregnancy; 1 point if they correctly name at least 3 danger signs for women during the first six weeks after childbirth; and 1 point if they correctly name at least 3 danger signs for newborns. Scores range from 0 to 4 with higher scores representing greater knowledge.	Measured 6-8 weeks after the end of pregnancy

Collaborators and Investigators

• Sponsor: Swiss Tropical & Public Health Institute
• Collaborators: Centre Suisse de Recherches Scientifiques en Cote d'Ivoire

Study record dates

Study Major Dates

• Study Start (Estimated): September 1, 2026
• Primary Completion (Estimated): May 1, 2027
• Study Completion (Estimated): May 1, 2027

Study Registration Dates

• First Submitted: September 8, 2026
• First Submitted That Met QC Criteria: September 8, 2026
• First Posted (Actual): September 14, 2026

Study Record Updates

• Last Update Posted (Actual): September 17, 2026
• Last Update Submitted That Met QC Criteria: September 14, 2026
• Last Verified: September 1, 2026

More Information

Terms related to this study

• Keywords: Pregnancy; Postpartum; Antenatal; Maternal health; Stillbirth; Côte d'Ivoire; Information intervention; west Africa
• Additional Relevant MeSH Terms: Urogenital Diseases; Pathologic Processes; Female Urogenital Diseases and Pregnancy Complications; Pregnancy Complications; Death; Fetal Death; Pathological Conditions, Signs and Symptoms; Stillbirth
• Other Study ID Numbers: 2026-19

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: De-identified data files and analytic code will be posted on public repositories at the time of publication of results.
• IPD Sharing Time Frame: We plan to share IPD and supporting information at the time of publication.
• IPD Sharing Access Criteria: IPD and supporting information will be made available on public repositories.
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL; SAP; ICF; ANALYTIC_CODE

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No